InvestorsHub Logo
Followers 51
Posts 9097
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Tuesday, 04/11/2023 9:11:52 AM

Tuesday, April 11, 2023 9:11:52 AM

Post# of 13469
$MRNA announced clinical and program updates this morning and noted that its second Phase 3 trial (P302) of its flu vaccine, mRNA-1010, did not meet the statistical threshold necessary to declare early success. The DSMB did not identify any safety concerns!

relax....They'll send the details in due course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News